<DOC>
	<DOC>NCT00766090</DOC>
	<brief_summary>The purpose of this study is to compare once and twice daily GW685698 in asthma</brief_summary>
	<brief_title>Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Key Clinical diagnosis of Asthma Reversibility ≥ 12% and ≥200mls reversibility of FEV1 within approximately 30minutes following 2 to 4 puffs of albuterol FEV1 between 4085% predicted Currently on short acting beta2 agonist therapy Key History of life threatening asthma Respiratory Infection or oropharyngeal candidiasis Asthma exacerbation Uncontrolled disease or clinical abnormality Allergies Taking another Investigational medications or other prohibited medications</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>